GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Clinical Laserthermia Systems AB (OSTO:CLS B) » Definitions » 5-Year EBITDA Growth Rate

Clinical Laserthermia Systems AB (OSTO:CLS B) 5-Year EBITDA Growth Rate : -5.20% (As of Mar. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Clinical Laserthermia Systems AB 5-Year EBITDA Growth Rate?

Clinical Laserthermia Systems AB's EBITDA per Share for the three months ended in Mar. 2024 was kr-1.58.

During the past 3 years, the average EBITDA Per Share Growth Rate was 7.90% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -5.20% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was -3.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Clinical Laserthermia Systems AB was 8.60% per year. The lowest was -89.10% per year. And the median was -8.80% per year.


Competitive Comparison of Clinical Laserthermia Systems AB's 5-Year EBITDA Growth Rate

For the Medical Devices subindustry, Clinical Laserthermia Systems AB's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Clinical Laserthermia Systems AB's 5-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Clinical Laserthermia Systems AB's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Clinical Laserthermia Systems AB's 5-Year EBITDA Growth Rate falls into.



Clinical Laserthermia Systems AB 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Clinical Laserthermia Systems AB  (OSTO:CLS B) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


Clinical Laserthermia Systems AB 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Clinical Laserthermia Systems AB's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Clinical Laserthermia Systems AB (OSTO:CLS B) Business Description

Traded in Other Exchanges
Address
Scheelevagen 2, Medicon village, Lund, SWE, 223 81
Clinical Laserthermia Systems AB develops and sells single-use products used during each treatment procedure of treatment of solid tumors cancers. Its products include Thermal Therapy System, Mobile Laser Unit, Laser Applicator Non-cooled and Tissue Temp Probe.

Clinical Laserthermia Systems AB (OSTO:CLS B) Headlines

No Headlines